Shaffer AL - Search Results

1

Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro.

Stanhope-Baker P, Hudson KM, Shaffer AL, Constantinescu A, Schlissel MS. Stanhope-Baker P, et al. Among authors: shaffer al. Cell. 1996 Jun 14;85(6):887-97. doi: 10.1016/s0092-8674(00)81272-6. Cell. 1996. PMID: 8681383 Free article.

2

The signaling activity of murine CD19 is regulated during cell development.

Krop I, Shaffer AL, Fearon DT, Schlissel MS. Krop I, et al. Among authors: shaffer al. J Immunol. 1996 Jul 1;157(1):48-56. J Immunol. 1996. PMID: 8683154

3

In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.

Shaffer AL, Peng A, Schlissel MS. Shaffer AL, et al. Immunity. 1997 Feb;6(2):131-43. doi: 10.1016/s1074-7613(00)80420-3. Immunity. 1997. PMID: 9047235 Free article.

4

A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.

Shaffer AL, Schlissel MS. Shaffer AL, et al. J Immunol. 1997 Aug 1;159(3):1265-75. J Immunol. 1997. PMID: 9233622

5

Pillars Article: Cell Type-Specific Chromatin Structure Determines the Targeting of V(D)J Recombinase Activity In Vitro. Cell. 1996. 85: 887-897.

Stanhope-Baker P, Hudson KM, Shaffer AL, Constantinescu A, Schlissel MS. Stanhope-Baker P, et al. Among authors: shaffer al. J Immunol. 2015 Dec 1;195(11):5106-16. J Immunol. 2015. PMID: 26589748 No abstract available.

6

Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy.

Phelan JD, Scheich S, Choi J, Wright GW, Häupl B, Young RM, Rieke SA, Pape M, Ji Y, Urlaub H, Bolomsky A, Doebele C, Zindel A, Wotapek T, Kasbekar M, Collinge B, Huang DW, Coulibaly ZA, Morris VM, Zhuang X, Enssle JC, Yu X, Xu W, Yang Y, Zhao H, Wang Z, Tran AD, Shoemaker CJ, Shevchenko G, Hodson DJ, Shaffer AL 3rd, Staudt LM, Oellerich T. Phelan JD, et al. Among authors: shaffer al 3rd. Cancer Cell. 2024 Feb 12;42(2):238-252.e9. doi: 10.1016/j.ccell.2023.12.019. Epub 2024 Jan 11. Cancer Cell. 2024. PMID: 38215749

7

Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.

Yang Y, Kelly P, Shaffer AL 3rd, Schmitz R, Yoo HM, Liu X, Huang DW, Webster D, Young RM, Nakagawa M, Ceribelli M, Wright GW, Yang Y, Zhao H, Yu X, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza L, Staudt LM. Yang Y, et al. Among authors: shaffer al 3rd. Cancer Cell. 2016 Apr 11;29(4):494-507. doi: 10.1016/j.ccell.2016.03.006. Cancer Cell. 2016. PMID: 27070702 Free PMC article.

8

BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. Shaffer AL, et al. Immunity. 2000 Aug;13(2):199-212. doi: 10.1016/s1074-7613(00)00020-0. Immunity. 2000. PMID: 10981963 Free article.

9

Lymphoid malignancies: the dark side of B-cell differentiation.

Shaffer AL, Rosenwald A, Staudt LM. Shaffer AL, et al. Nat Rev Immunol. 2002 Dec;2(12):920-32. doi: 10.1038/nri953. Nat Rev Immunol. 2002. PMID: 12461565 Review.

10

Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation.

Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, Singh H. Sciammas R, et al. Among authors: shaffer al. Immunity. 2006 Aug;25(2):225-36. doi: 10.1016/j.immuni.2006.07.009. Immunity. 2006. PMID: 16919487 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters